Related Experiment Video
Updated: Mar 17, 2026

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
Published on: November 9, 2016
Clonidine Overdose in a Toddler Due to Accidental Ingestion of a Compounding Cream
Insights
A toddler experienced severe toxicity after ingesting a compounded cream, with high clonidine levels causing apnea and vital sign fluctuations. Prompt supportive care led to a full recovery, highlighting the risks of pediatric exposure to such medications.
Area of Science:
- Pediatric Toxicology
- Emergency Medicine
- Clinical Pharmacology
Background:
- Accidental ingestion of compounded medications in children presents unique toxicological challenges.
- Therapeutic compounding creams often contain multiple active pharmaceutical ingredients, increasing the risk of adverse events.
Observation:
- A 22-month-old child ingested a compounded cream containing camphor, gabapentin, clonidine, ketoprofen, and lidocaine.
- The child presented with altered mental status, apnea, hypothermia, bradycardia, and hypotension.
- Serum analysis revealed a supratherapeutic clonidine level (2.6 ng/mL) with undetectable levels of other components.
Findings:
- Severe toxicity, including respiratory depression and hemodynamic instability, was observed following ingestion.
- The patient's clinical presentation was primarily attributed to clonidine toxicity.
- Supportive care, including mechanical ventilation and management of vital signs, was effective in resolving symptoms.
Implications:
- Healthcare providers should maintain a high index of suspicion for toxicity from compounded medications in pediatric ingestions.
- Enhanced parental education regarding the safe storage and administration of compounded medications is crucial.
- This case underscores the potential for severe adverse events even with limited exposure to certain pharmaceutical compounds.
Abstract:
A 22-month-old girl without any significant medical history accidentally consumed a small amount of a therapeutic compounding cream that contained camphor, gabapentin, clonidine, ketoprofen, and lidocaine. Upon presentation to the emergency department, the child exhibited immediate onset of altered mental status with wide fluctuation in her vital signs, which included intermittent apnea requiring bag-valve mask assistance and endotracheal intubation. Serum laboratory analysis measured a clonidine level of 2.6 ng/mL and undetectable camphor, gabapentin, and ketoprofen levels. While on mechanical ventilation, the patient exhibited hypothermia, bradycardia, and hypotension; all of which responded to supportive care. After approximately 12 hours in the intensive care unit, the patient was successfully extubated and remained asymptomatic. This unique case of a patient with brief, unintentional oral exposure to a compounding cream, who demonstrated severe toxicity despite only a measured, supratherapeutic clonidine concentration, is discussed. Emergency physicians and pediatricians should be alert to the potential for exposure of pediatric patients to these medicinal compounds. Furthermore, parents must be made aware of the potential dangers of compounded medications and ensure their proper usage and storage.
Related Concept Videos
Drug Dosing: Infants and Children
Toxidromes: Clinical Features
Pharmaceutical Poisoning: Potential Scenarios
Pharmaceutical Poisoning: Treatment Strategies
Prevention of Further Absorption of Poison
Drug Toxicity: Overview

